# Sunshine Lake Pharma

**Canonical:** https://apis.io/providers/sunshine-lake-pharma/  
**Website:** https://www.hecpharm.com/  
**APIs profiled:** 0

Sunshine Lake Pharma (Guangdong East Sunshine Pharmaceutical Co., Ltd., also known as HEC Pharm) is a Chinese pharmaceutical company established in 2003 and part of the Dongyangguang (HEC) Group. It engages in drug research, development, production, and commercialization across innovative drugs, improved formulations, generics, and biosimilars, focused on infections, chronic diseases, and oncology. Notable products include oseltamivir phosphate (influenza), sofosbuvir-based hepatitis C therapy, and insulin glargine (diabetes). It is a manufacturer with no public developer or API surface. Surfaced as a portfolio company of idg-capital and added to the API Evangelist network.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Healthcare, Pharmaceuticals, Biotechnology, Life Sciences, Drug Manufacturing, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/sunshine-lake-pharma/). Scores are computed from the provider's own public artifacts under a published rubric.